Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-03 Sale |
2022-10-03 8:30 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor |
15,900 | $148.5 | $2,361,150 | 0 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:29 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
3,035,001 | $148.5 | $450,697,649 | 0 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:28 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer |
6,177 | $148.5 | $917,285 | 0 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:27 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
10,640 | $148.5 | $1,580,040 | 0 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:27 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
6,682 | $148.5 | $992,277 | 1,614 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:26 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
922,941 | $148.5 | $137,056,739 | 830,891 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:25 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
14,226 | $148.5 | $2,112,561 | 0 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:25 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director |
2,900 | $148.5 | $430,650 | 0 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:24 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
4,292 | $148.5 | $637,362 | 0 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:23 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
2,583,658 | $148.5 | $383,673,213 | 0 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:23 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
16,464 | $148.5 | $2,444,904 | 0 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:23 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
22,362 | $148.5 | $3,320,757 | 0 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:20 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations |
11,653 | $148.5 | $1,730,471 | 0 (Direct) |
View |
| 2022-08-19 Purchase |
2022-08-22 7:00 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
38,000 | $148.04 | $5,625,676 | 2,583,658 (Direct) |
View |
| 2022-05-10 Sale |
2022-05-12 8:58 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
4,200 | $141.5 | $594,300 | 6,315 (Direct) |
View |
| 2020-06-15 Sale(A) |
2022-02-11 9:41 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
41,306 | $68.49 | $2,829,152 | 999,914 (Indirect Direct) |
View |
| 2020-06-11 Sale(A) |
2022-02-11 9:40 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
50,953 | $65.19 | $3,321,623 | 1,139,915 (Indirect Direct) |
View |
| 2022-01-19 Sale |
2022-01-24 06:01 am |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
9,375 | $117.01 | $1,097,003 | 13,390 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-10-03 Other |
2022-10-05 5:40 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Biohaven Pharmaceutical Holding Co Ltd. 10% Owner |
35,839,857 | $0 | 71,679,714 (Direct) |
View |
Ownership |
2022-09-28 8:50 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Biohaven Pharmaceutical Holding Co Ltd. 10% Owner |
0 | $0 | 100 (Direct) |
View |
| 2022-05-10 Exercise |
2022-05-12 8:58 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
2,250 | $53.76 | 6,315 (Direct) |
View |
| 2022-05-10 Exercise |
2022-05-12 8:58 pm |
N/A 2029-12-05 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
2,250 | $0 | 6,315 (Direct) |
View |
| 2022-05-11 Option Award |
2022-05-12 8:57 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Antonijevic Irina Director |
5,070 | $0 | 5,070 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 9:04 pm |
N/A 2032-04-27 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
8,239 | $0 | 8,239 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 9:03 pm |
N/A 2032-04-27 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director |
8,239 | $0 | 8,239 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 9:02 pm |
N/A 2032-04-27 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director |
8,239 | $0 | 8,239 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 9:00 pm |
N/A 2032-04-27 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director |
8,239 | $0 | 8,239 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 8:59 pm |
N/A 2032-04-27 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director |
8,239 | $0 | 8,239 (Direct) |
View |
| 2022-04-28 Option Award |
2022-04-29 8:58 pm |
N/A 2032-04-27 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Heffernan Michael Thomas Director |
8,239 | $0 | 8,239 (Direct) |
View |
| 2021-05-21 Ownership |
2022-02-11 9:44 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
170,000 | $0 | 1,308,989 (Indirect) |
View |
| 2021-03-08 Ownership |
2022-02-11 9:44 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
1,474,051 | $0 | 1,308,989 (Direct) |
View |
Ownership |
2022-02-11 9:44 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director |
0 | $0 | 1,308,989 (Indirect) |
View |
| 2021-06-21 Ownership |
2022-02-11 9:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
47,283 | $0 | 387,985 (Indirect) |
View |
Ownership |
2022-02-11 9:15 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer |
0 | $0 | 387,985 (Indirect) |
View |
| 2022-01-19 Exercise |
2022-01-24 06:01 am |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
3,750 | $53.76 | 13,390 (Direct) |
View |
| 2022-01-19 Exercise |
2022-01-24 06:01 am |
N/A 2029-12-05 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
5,670 | $0 | 13,390 (Direct) |
View |
| 2022-01-19 Exercise |
2022-01-24 06:01 am |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
1,920 | $32.42 | 13,390 (Direct) |
View |
| 2022-01-10 Tax Withholding |
2022-01-12 9:12 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
464 | $128.87 | 10,720 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-12 9:12 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
1,000 | $0 | 10,720 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-12 9:10 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer |
937 | $0 | 17,402 (Indirect) |
View |
| 2022-01-10 Exercise |
2022-01-12 9:04 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director |
1,875 | $0 | 12,515 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:19 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer |
26,000 | $0 | 26,000 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:18 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
10,500 | $0 | 22,176 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
551 | $123.86 | 22,176 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
342 | $128.87 | 22,176 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer |
2,125 | $0 | 22,176 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:18 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
15,000 | $0 | 29,934 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
409 | $123.86 | 29,934 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
522 | $128.87 | 29,934 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer |
1,875 | $0 | 29,934 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:18 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
34,500 | $0 | 64,135 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
1,800 | $123.86 | 64,135 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:18 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer |
3,750 | $0 | 64,135 (Direct) |
View |